Professor Cleo Kontoravdi is a Professor of Biological Systems Engineering at the Department of Chemical Engineering, Imperial College London, within the Faculty of Engineering. Her roles include Director of Postgraduate Studies (2021–present) and Postgraduate Admissions Tutor (2018–2021). She holds affiliations with key research centers such as the Centre for Process Systems Engineering, Centre for Synthetic Biology, and Future Vaccine Manufacturing Research Hub. Her research focuses on applying systems engineering principles to bioprocessing, integrating model-based tools like sensitivity analysis and optimization with experimental work on mammalian cell cultures and vaccine production. Key areas include metabolic flux analysis, media optimization, and multiscale modeling. Her recent publications highlight advancements in hybrid modeling frameworks, mRNA vaccine process design, and metabolic engineering of CHO cells. She actively contributes to vaccine manufacturing strategies and sustainable biopharmaceutical supply chains. Education: PhD (2007) and MEng (2002) in Chemical Engineering from Imperial College London. Professional experience spans academic roles (since 2007) and industry R&D at Lonza Biologics (2006–2007). Her work bridges computational biology, bioprocess engineering, and systems biology, addressing challenges in vaccine development and production efficiency. Awards: Not explicitly listed in the provided text. Research grants and collaborations are implied through her involvement in high-impact projects like the Future Vaccine Manufacturing Hub. She advises on bioprocess optimization, glycoengineering, and biomanufacturing sustainability.










